New blood marker may predict Sjögren's Flare-Ups
NCT ID NCT03003572
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study is looking for a better way to track disease activity in people with primary Sjögren's syndrome, a chronic autoimmune disease that causes dryness and can affect organs. Researchers will test a new blood marker called anti-Ro/SSA IgE in 185 participants to see if it is higher in those with active disease. The goal is to find a reliable tool to help doctors monitor the condition and guide treatment.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PRIMARY SJÖGREN'S SYNDROME are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
CH Lyon Sud
RECRUITINGLyon, 69495, France
Contact
Contact
Contact
Contact
Contact
-
CH Pierre Oudot
NOT_YET_RECRUITINGBourgoin, 38300, France
Contact
Contact
-
CHU Estaing - Clermont Ferrand
RECRUITINGClermont-Ferrand, 63000, France
Contact
Contact
Contact
Contact
-
CHU Grenoble Alpes
RECRUITINGGrenoble, 38700, France
Contact
Contact
Contact
Contact
Contact
Contact
-
CHU Reims
NOT_YET_RECRUITINGReims, France
Contact
-
Chu Saint-Etienne
RECRUITINGSaint-Etienne, 42055, France
Contact
Contact
Contact
Contact
Contact
Contact
Contact
Contact
Contact
Contact
Contact
Contact
-
Hôpital Edouard Herriot - CHU Lyon
NOT_YET_RECRUITINGLyon, France
Contact
Contact
Contact
-
Hôpital de la Croix Rousse
RECRUITINGLyon, 69317, France
Contact
Contact
Contact
Contact
Contact
Contact
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- New drug shows promise for Sjögren's syndrome in early trial
- Immune retraining: could CAR-Treg cells tame autoimmune disease?
- How many autoimmune patients try alternative therapies? new study counts
- Sjögren's drug shows promise in safety extension trial
- Exercise program shows promise for rheumatic pain and mood
- New weekly shot aims to tame Sjögren's Flare-Ups